FDA: ANDA Submissions—Amendments to ANDAs Under GDFUA [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2018-08-09 10:52  – Posting: # 19161
Views: 591

Dear all,

a new Guidance for Industry

ANDA Submissions—Amendments to Abbreviated New Drug Applications Under GDUFA

was published in the Federal Register on July 5th.
See esp. APPENDIX A: MAJOR DEFICIENCIES, B. Bioequivalence Deficiencies.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,300 posts in 4,102 threads, 1,316 registered users;
online 15 (2 registered, 13 guests [including 10 identified bots]).

I have no opinion about ‘incurred samples’ –
an expression which has no easily understandable
meaning for me in the English language.    Nick Holford

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5